The combined positive score (CPS) for PD-L1, defined as the number of PD-L1+ cells, including tumor cells and immune cells (macrophages and lymphocytes), relative to the total number of tumor cells, is an important biomarker of cancer progression, with a CPS ≥ 1 considered a positive PD-L1 tumor. Here, CD274 is linked to cancer.